Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

Incyte

Status

Conditions: STAT1 Gain-of-Function Disease

Treatments: Drug: Itacitinib

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT05561985

I-39110-19-03

Details and patient eligibility

About

Expanded access use of Itacitinib to treat a single patient with aplastic anemia.

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria